Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metas...
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
About this item
Full title
Author / Creator
Schmid, Peter, Prof , Rugo, Hope S, Prof , Adams, Sylvia, Prof , Schneeweiss, Andreas, Prof , Barrios, Carlos H, MD , Iwata, Hiroji, Prof , Diéras, Véronique, MD , Henschel, Volkmar, PhD , Molinero, Luciana, PhD , Chui, Stephen Y, MD , Maiya, Vidya, MD , Husain, Amreen, MD , Winer, Eric P, Prof , Loi, Sherene, Prof , Emens, Leisha A, Prof and IMpassion130 Investigators
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
SummaryBackgroundImmunotherapy in combination with chemotherapy has shown promising efficacy across many different tumour types. We report the prespecified second interim overall survival analysis of the phase 3 IMpassion130 study assessing the efficacy and safety of atezolizumab plus nab-paclitaxel in patients with unresectable, locally advanced o...
Alternative Titles
Full title
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Rugo, Hope S, Prof
Adams, Sylvia, Prof
Schneeweiss, Andreas, Prof
Barrios, Carlos H, MD
Iwata, Hiroji, Prof
Diéras, Véronique, MD
Henschel, Volkmar, PhD
Molinero, Luciana, PhD
Chui, Stephen Y, MD
Maiya, Vidya, MD
Husain, Amreen, MD
Winer, Eric P, Prof
Loi, Sherene, Prof
Emens, Leisha A, Prof
IMpassion130 Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2320638875
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2320638875
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(19)30689-8
